VERSANT VENTURE MANAGEMENT, LLC – CRISPR Therapeutics AG Transaction History
VERSANT VENTURE MANAGEMENT, LLC portfolio value:
$32.58M
portfolio value
VERSANT VENTURE MANAGEMENT, LLC quarter portfolio value change:
+7.54%
quarter
CRISPR Therapeutics AG 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | 0.00% | 0 shares | 2.28M | $65.35 | 498.55K | |
| Q2 2022 | share | 0.00% | 0 shares | -997K | $60.77 | 498.55K | |
| Q1 2022 | share | 0.00% | 0 shares | -6.48M | $62.77 | 498.55K | |
| Q4 2021 | share | 0.00% | 0 shares | -18.02M | $78.85 | 498.55K | |
| Q3 2021 | share | Decrease | -1.97% | -10K shares | -26.52M | $111.93 | 498.55K |
| Q2 2021 | share | Decrease | -67.29% | -1.04M shares | -107.14M | $161.89 | 508.55K |
| Q1 2021 | share | Decrease | -48.86% | -1.48M shares | -276.05M | $121.85 | 1.55M |
| Q4 2020 | share | Decrease | -16.28% | -591.19K shares | 161.77M | $153.11 | 3.04M |
| Q3 2020 | share | Decrease | -13.18% | -551.40K shares | -3.66M | $83.64 | 3.63M |
| Q2 2020 | share | Decrease | -0.54% | -22.55K shares | 130.18M | $73.49 | 4.18M |
| Q1 2020 | share | 0.00% | 0 shares | -78.91M | $42.41 | 4.20M | |
| Q4 2019 | share | Decrease | -0.67% | -28.25K shares | 82.59M | $60.91 | 4.20M |
| Q3 2019 | share | Decrease | -0.35% | -15.01K shares | -26.57M | $40.99 | 4.23M |
| Q2 2019 | share | 0.00% | 0 shares | 48.35M | $47.1 | 4.24M | |
| Q1 2019 | share | Increase | +17.73% | 640.01K shares | 48.66M | $35.72 | 4.24M |
| Q4 2018 | share | 0.00% | 0 shares | -56.94M | $28.57 | 3.60M | |
| Q3 2018 | share | 0.00% | 0 shares | -52.00M | $44.35 | 3.60M | |
| Q2 2018 | share | Decrease | -21.65% | -997.36K shares | 1.50M | $58.76 | 3.60M |
| Q1 2018 | share | Increase | 0.00% | 4.60M shares | 210.55M | $45.71 | 4.60M |